What are the long-term continence and recurrence rates of fistulotomy versus lift surgeries in a non-smoking, non-diseased patient with a low transphincteric (anal) fistula?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fistulotomy vs LIFT for Low Transsphincteric Fistula in Non-Smoking, Non-Diseased Patients

For a non-smoking, non-diseased patient with a low transsphincteric fistula, fistulotomy remains the superior choice with near-perfect healing rates (83.6-100% primary healing) but carries a 28% risk of major incontinence, while LIFT offers excellent continence preservation (1.6% incontinence) with 82% primary healing—making LIFT the preferred first-line approach when sphincter preservation is prioritized. 1, 2

Fistulotomy: The Traditional Gold Standard

Healing and Recurrence Rates

  • Primary healing rate of 83.6% in a large multicenter study of 537 patients, with secondary healing reaching 90.3% after treatment of recurrences 2
  • 5-year healing rate of 81% (95% CI 0.71-0.85) based on Kaplan-Meier analysis 2
  • Recurrence rate of 16.4% in the primary treatment group, though most respond to secondary intervention 2
  • In carefully selected patients without proctitis, healing rates approach 100% 3

Continence Outcomes: The Critical Concern

  • Only 26.3% of patients maintain perfect continence (Vaizey score 0) after fistulotomy 2
  • Major incontinence (Vaizey score >6) occurs in 28% of patients, which is substantially higher than previously believed 2
  • Mean Vaizey incontinence score of 4.67 (SD 4.80) indicates measurable functional impairment in most patients 2
  • The risk of impaired continence following division of even the lower third of the external sphincter is not insignificant, especially in female patients with anterior fistulas 1

LIFT Procedure: The Sphincter-Preserving Alternative

Healing and Recurrence Rates

  • Primary healing rate of 82% in low transsphincteric fistulas at median 19.5-month follow-up 1
  • Overall healing rate of 100% when including conversion to intersphincteric fistula followed by sphincter-preserving fistulotomy in the 18% who failed primary LIFT 1
  • In broader populations including complex fistulas, success rates range from 69-77% with median follow-up over 1 year 4
  • Recurrence rates of 1.6% in meta-analyses, though more recent data suggests potential underreporting with true rates possibly reaching 21% 4, 5
  • Median time to failure is approximately 4 months when recurrence occurs 5

Continence Outcomes: The Major Advantage

  • Incontinence rate of only 1.6%, dramatically lower than fistulotomy 5
  • No significant change in median incontinence scores at 6 months post-surgery 1
  • Some studies show 53% of LIFT patients actually experienced improvement in fecal continence postoperatively 5
  • LIFT avoids division of the external anal sphincter entirely, which is essential for patients with compromised anal sphincters 1

Clinical Decision Algorithm

Step 1: Verify Patient Eligibility for Either Procedure

  • Confirm absence of active proctitis via examination—this is an absolute contraindication to both procedures 4, 3, 6
  • Verify single, non-branching fistula tract with well-epithelialized anatomy, particularly important for LIFT 4
  • Exclude anterior fistulas in female patients from fistulotomy consideration due to high incontinence risk 3, 6
  • Confirm patient is non-smoking—smoking increases LIFT failure risk 3.2-fold 5

Step 2: Choose Based on Sphincter Preservation Priority

For patients prioritizing continence (recommended default):

  • Proceed with LIFT as first-line therapy given 82% primary healing with only 1.6% incontinence risk 1, 5
  • If LIFT fails, the transsphincteric fistula converts to intersphincteric, allowing subsequent sphincter-preserving fistulotomy 1
  • This staged approach achieves 100% ultimate healing while minimizing sphincter damage 1

For patients accepting continence risk for maximum healing:

  • Fistulotomy achieves 83.6% primary healing but with 28% major incontinence risk 2
  • This approach is reasonable only after explicit counseling about the 72% chance of some degree of continence impairment 2

Step 3: Optimize Surgical Timing

  • Ensure any prior sepsis is fully drained with loose setons before attempting definitive closure 5
  • Wait for tract maturation into fibrotic tube with granulation tissue, particularly for LIFT 4
  • Confirm well-epithelialized tract on examination or imaging before proceeding 4

Critical Caveats and Common Pitfalls

Patient Selection Errors

  • Attempting fistulotomy in patients with prior sphincter division is catastrophic—these patients absolutely require sphincter-preserving approaches 5
  • Performing fistulotomy on anterior fistulas in women leads to devastating incontinence due to short anterior sphincter 3, 6
  • Proceeding with either procedure in the presence of active proctitis dooms the operation to failure 4, 5, 3

Underestimating Fistulotomy's Continence Impact

  • The traditional teaching that "low fistulotomy is safe" is contradicted by modern data showing only 26.3% maintain perfect continence 2
  • Division of even the lower third of external sphincter carries significant risk, particularly in women and those with baseline sphincter compromise 1
  • Patients must be counseled that "low risk" does not mean "no risk"—the majority will have some measurable functional change 2

LIFT-Specific Technical Considerations

  • Smoking at time of surgery significantly increases failure (HR 3.2), making smoking cessation counseling mandatory 5
  • MRI evidence of fibrotic tract post-LIFT predicts excellent long-term outcomes with no reinterventions 4
  • Declaring success based on clinical healing alone without radiological confirmation may miss persistent tracts 5
  • True recurrence rates may be higher than initially reported (21% vs 1.6%) due to heterogeneous follow-up in early studies 4, 5

Long-Term Monitoring

  • Follow-up at weeks 1-2,4,8, and months 4-6 to assess infection, external opening healing, and identify early recurrence 5
  • Consider MRI if clinical uncertainty exists about tract obliteration, particularly given potential for underreported recurrence 5
  • Complete epithelialization requires 6-12 months after fistulotomy, during which the tract undergoes progressive fibrosis 6
  • Wait at least 6 months after complete wound healing before resuming activities that stress the anal canal 6

The Bottom Line for Your Patient

In a healthy, non-smoking patient with a low transsphincteric fistula and no proctitis, LIFT should be the first-line recommendation given its 82% primary healing rate, 100% ultimate healing when including salvage procedures, and dramatically superior continence profile (1.6% vs 28% major incontinence). 1, 2, 5 Fistulotomy should be reserved for the minority who fail LIFT and explicitly accept the high probability of continence impairment, or for the rare patient who prioritizes single-procedure success over functional preservation after thorough counseling. 2

References

Research

Ligation of the intersphincteric fistula tract in low transsphincteric fistulae: a new technique to avoid fistulotomy.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2013

Guideline

Management of Perianal Fistulas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ligation of Intersphincteric Fistula Tract (LIFT) for Complex Perianal Fistulas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Long-Term Prognosis After Fistulotomy with ≤30% Sphincter Division

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What treatment plan is recommended for a patient with a history of low transanal fistulotomy (involving less than 30% of the anal sphincter) to promote healing, manage discomfort, and potentially restore anal sensations and sexual well-being?
Can a patient with a history of low transsphincteric fistulotomy and a slight anatomical deformity at the fistulotomy site safely engage in anal sex?
What is the best treatment option for a low transphincteric fistula in a patient with a limited life expectancy of 2 years and expected decline in functional status, including potential loss of mobility and cognitive function?
Can pelvic care therapy, including pelvic floor physical therapy, improve the enjoyment of anal sex in a gay male patient with a history of low transsphincteric anal fistula and previous fistulotomy?
Can over tense muscles 6 months after a low transsphincteric fistulotomy (a surgical procedure for anal fistula) cause loss of libido in a patient, and can treatment targeting muscle relaxation improve libido and sensations?
What is the extent of safe rectal stretching for a patient 12 months after a healed fistulectomy due to a history of anal fistula?
What is the recommended treatment for a pregnant woman with possible pyelonephritis?
What is the definition, classification, etiology, risk factors, epidemiology, pathogenesis, clinical presentation, diagnosis, diagnostic criteria, differential diagnosis, treatment, management, prevention, and recommendations for Polycythemia Vera (PV)?
Will increasing my duloxetine dose from 20mg to 30mg exacerbate my anxiety symptoms?
Is a renal ultrasound recommended for a pregnant woman with suspected pyelonephritis?
What is the recommended oral antibiotic treatment for a pediatric patient with left lower zone consolidation suggestive of pneumonia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.